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T WENTY years of major public health protection have been pro-
vided since enactment of the Federal Food, Drug, and Cos-
metic Act of 1938. The Food and Drug Administration, a con-
stituent of the United States Department of Health, Education,
and Welfare, enforces this Act and thereby carries out the pur-
pose of Congress to insure that foods are safe, pure, and whole-
some, and made under sanitary conditions; drugs and therapeu-
tic devices are safe and effective for their intended uses; cos-
metics are safe and prepared from appropriate ingredients; and
that all of these products are honestly and informatively labeled
and packaged. Man and animals are provided for in this law.
FDA also enforces the Caustic Poison Act, The Filled Milk
Act, the Import Milk Act, and the Tea Act. These several
statutes have also been of value in protecting the public.
The Caustic Poison Act requires poison warnings and anti-
dotes on the labeling of twelve caustic and corrosive substances.
The Filled Milk Act prohibits the substitution of the butter fat
content with other fat except for special dietary products. The
Import Milk Act prohibits the importation of milk into the
United States except from sources that have been approved
either through our inspection facilities or by arrangement with
the health authorities of the country of origin. The Tea Act
prohibits the importation of tea into the United States except
that which has been examined and passed by a Government tea
examiner.
The Federal Food and Drugs Act of 1906, popularly referred
to as the Wiley "Pure Food Law," was one of the first of a
number of statutes designed to regulate interstate commerce. It
set forth the rules of conduct producers were to observe in order
to enjoy the benefits of interstate commerce in foods and drugs.
This pioneer legislation was superseded by the Food, Drug, and
Cosmetic law of 1938.
* Associate Medical Director, Bureau of Medicine, U. S. Dept. of Health,
Education, and Welfare, Food and Drug Administration, Washington, D. C.;
etc.
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The importance that the Federal Food, Drug, and Cosmetic
Act has in our national life and the character of the legal prob-
lems arising under it, received growing recognition in the years
following World War II. First, the New York State Bar As-
sociation, then the American Bar Association, established a sec-
tion devoted exclusively to food and drug problems and the pro-
motion of education in this field, for undergraduates, graduates,
and practicing attorneys. In 1949 the Food Law Institute was
established to implement their educational and research objec-
tives.
Concurrent with the legal developments over the past two
decades, medical practice has rapidly improved through the in-
troduction of many new therapeutic agents and procedures. The
pharmaceutical industry in its keen awareness of the physician's
need has energetically developed new drugs in an unprecedented
manner to supply many chemotherapeutic agents to improve the
practice of medicine. The Federal Government has actively par-
ticipated in many ways to encourage these important develop-
ments to give this nation an abundant supply of effective and
safe drugs. During the same period there have been many new
developments in the food and cosmetic industries.
Foods
The public is seeking more and more to have food con-
veniently prepared, diversified in nature, and in better packages.
Industrial scientists must use a wide variety of substances for-
merly not used in foods in order to meet these demands. In the
development of these newer foodstuffs, the chance for error is
apparent. Both industry and the Government must be on the
alert to prevent the introduction of substances which may be
detrimental to the consumer. While no food known to be in-
jurious is being marketed today, authority is needed to insure
the safety of products containing new chemical additives. There
is presently pending before the Congress proposed legislation
that would require the pretesting for safety of chemical additives
to food. This is an important piece of legislation which is needed
to close a major gap in the present law. At present a manu-
facturer may use a new additive without first establishing its
safety. Of course, if the Government eventually establishes that
the substance is unsuitable for such use, there is adequate au-
thority under the law to force discontinuance of its use in foods
2https://engagedscholarship.csuohio.edu/clevstlrev/vol8/iss1/9
ADVERTISED PRODUCTS-FOOD AND DRUG ACT
shipped in interstate commerce, and for taking action against
the careless manufacturer. However, it takes time to develop
the data to establish the safety of many additives, and under
the present law, this use can go unchecked for considerable
periods. Under the proposed legislation, which the Food and
Drug Administration strongly favors, it would be illegal to use
an additive without first establishing through a procedure pro-
vided by law that the substance is in fact safe for its intended
use. Avoidance of potential health hazards from our food supply
is a grave concern of FDA.
In cooperation with the United States Department of Ag-
riculture and the National Milk Producers Federation an in-
tensive program has been undertaken to eliminate antibiotics
and pesticide residues from the milk supply.
On July 22, 1956, The Pesticide Chemicals Amendment be-
came fully effective. This assures that only safe quantities of
pesticides can be used on raw agricultural commodities. Since
1954 when the amendment was enacted over 1,450 tolerances or
exemptions have been established for 87 pesticide chemicals.
A fundamental program of FDA is the establishment of food
standards. The adducing of facts to support food standards and
establishing the public hearing record, on which the standards
had to be based, developed into a very cumbersome, time-con-
suming and expensive process for Government and industry
alike. In 1954, Congress passed unanimously the "Hale Amend-
ment" sponsored by the Food, Drug, and Cosmetic Law Sec-
tion of the New York Bar Association and endorsed by food
manufacturers and the Secretary of the Department of Health,
Education, and Welfare. Under the new program, proposals
and orders are published and may become effective without
hearing unless some one files objections and requests a public
hearing. Only those issues set up by written objection to the
proposal must be heard.
The sanitation of our food supply is a long recognized es-
sential to good health. With the development of processed con-
venience foods, utilizing complex methods, constant vigilance
in their preparation is needed to preclude opportunity for con-
tamination.
Debasement or sophistication of foods is prohibited under
the Act; substandard and short weight products are also illegal.
These are regarded fundamentally as economic violations,
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In the instance of special dietary foods, special labeling re-
quirements are required to provide information dealing with
vitamin and mineral content and other dietary properties. The
minimum daily dietary requirements of vitamins and minerals
in human nutrition were established at public hearings and the
labeling of products containing certain vitamins and minerals
is set forth in the regulations. An important dietary food group
recently covered by regulations consists of items of low sodium
content. They must be labeled with the amount of sodium in
100 grams of the food and in an average serving. This is a public
health protection for those whose sodium intake must be re-
stricted.
The representations made for foods must be truthful. The
blatant representations made for simple nutritional adjuncts, both
written and oral, for the prevention and cure of serious diseases
have served as the bases for numerous court cases. In June
1957 the Supreme Court denied certiorari in two important cases
involving health claims made for "health foods." FDA charged
that such claims made these articles drugs and resulted in their
being misbranded since they failed to bear adequate directions
for use for the conditions described by their promoters. Both
claimants argued that the legal issue involved was false ad-
vertising which is not controlled by the Act. Having lost their
appeals, both were sent to the penitentiary, amidst lengthy pro-
tests of their followers. The problem of quackery and its eradi-
cation in the field of nutrition is a major public health matter,
just as it is in the general field of medicine. There is need for
an extensive public education program to expose the health
quacks as well as to combat ignorance of what constitutes food
nutrition.
Drugs and Devices
The Act regulates the labeling of drugs and devices with
respect to adulteration and misbranding in a manner parallel
to foods. Drugs and devices must conform with the strength,
purity or quality which they purport or are required through
official compendia (such as the U. S. Pharmacopeia and Na-
tional Formulary) to possess. Their labeling must be truthful.
False or misleading therapeutic claims made for a drug or device
are violative and constitute a major problem frequently neces-
sitating regulatory action under Section 502 (a) of the Act. All
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written, printed and graphic matter used to promote the sale
of the drug or device, whether in the retail package or dis-
tributed separately, must avoid any false or misleading state-
ment regarding the composition of the article or the effects
produced.
Required Labeling Information
The labeling must state the name and address of the manu-
facturer, packer or distributor, and also a statement of quantity
of contents.
The label of non-official drugs must list each active ingredient
by its common or usual name, and if alcohol is present, it must
be declared as to the quantity, kind and proportion contained.
Whether present as an active ingredient or not, a declaration
must be made of the name and quantity or proportion of any
bromide, ether, chloroform, acetanilid, acetphenetidin, amidopy-
rine, atropine, hyoscyamine, arsenic, digitalis, digitalis gluco-
sides, mercury, oubain, strophanthin, strychnine, thyroid, or
any derivatives of these drugs.
If the article contains any of a list of narcotic or hypnotic
substances, or any derivative of such substance which has been
found to be and by regulations designated as habit-forming, the
label must carry the statement: "WARNING-May be habit-
forming." The declaration must be in juxtaposition to the quan-
titative declaration of the drug. Section 502 (d) of the Act
names in this group alpha-eucaine, barbituric acid, beta-eucaine,
bromal, cannabis, carbromal, chloral, coca, cocaine, codeine,
heroin, marihuana, morphine, opium, paraldehyde, peyote, or
sulfonmethane.
Adequate directions for use are required to be provided in
the labeling of drugs and devices. In the case of articles sold
for lay use, proper indications for administration must appear
and adequate directions for such uses must be supplied. Drugs
which can be safely used only under the supervision of physicians
or dentists must bear the statement: "CAUTION: Federal law
prohibits dispensing without prescription." When this exemption
is used, the drug label must also provide the recommended or
usual dosage, the route of administration, if not for oral use,
and the quantity and proportion of each active ingredient. If not
for oral use, the names of all other ingredients must also be
given to inform the professional user fully. With prescription
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drugs, informative medical brochures are made available setting
forth detailed technical and clinical information relating to the
use of the article. For new drugs descriptive circulars are re-
quired to be submitted for critical review before the drug can
be released. This requirement serves to insure that the physician
will have accurate information to enable his safe and effective
use of the drug.
Potent drugs which may not be sold legally without prescrip-
tion may not be refilled without authorization from the pre-
scriber. It should be emphasized that this restriction to sell only
on prescription applies not only to those drugs which are toxic
or habit-forming, per se, but also to any drug, even though it
may be comparatively innocuous, if the only rational use of the
drug is in a condition which a layman could not reasonably be
expected to diagnose and treat for himself.
This section of the law deserves the particular attention of
the physician because of its intimate connection with the
physician-pharmacist-patient relationship. The public generally
is not yet adequately informed about the public health reasons
for restricting many of these drugs to prescription sale, and the
cooperation of the physician and pharmacist is needed to prevent
misunderstanding and ill will.
It should be clearly understood that the physician can au-
thorize refilling of his prescription as many times or for as long
a time as he feels necessary or desirable. He can do that by
noting on the original prescription or by subsequent written or
telephoned authorization to the pharmacist. A word of caution
is in order regarding the "ad lib" type of refill authorization
which makes a prescription refillable at the request of the patient
for an unlimited time. The practical reason for objecting to such
a refill authorization is that it is subject to abuse, and in our ex-
perience, is too often abused.
Another major health safeguard achieved through labeling
is the requirement that adequate warnings against unsafe use to
protect users be set forth in the labeling under section 502 (f) (2)
of the Act. Upon request, FDA will supply information con-
cerning suggested warning statements required for certain
articles.
The article must not be dangerous to health when used in
the dosage or with the frequency or duration prescribed, recom-
mended or suggested in its labeling.
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Illegal Sales of Drugs
In 1957, of 114 drug prosecution cases filed, 100 were based
on violative sales of prescription drugs. FDA investigations be-
gan after complaints were received from law-enforcement of-
ficials, physicians, social workers, and families of persons being
injured by the drugs.
In the 105 cases terminated in 1957, 145 individuals were
convicted on their own pleas or by the courts. In about 10 per-
cent of the cases the defendants were persons with no pro-
fessional training who sold the drugs at truck stops, general
stores, or through peddling. Seven individuals, some of them
previous offenders, were sentenced to serve jail sentences ranging
from 2 months to a year. On others, suspended jail sentences,
probation periods, and fines were imposed.
The determination of the legality of the dispensing of a drug
by a physician depends in full measure on whether or not there
is a bona fide doctor-patient relationship. A recent case decided
in favor of the Government involved a physician who dispensed
potent drugs without prescription and without an established
doctor-patient relationship; his conviction was upheld by the
Court of Appeals for the Fifth Circuit.
Drug Adulteration
FDA's attention to drugs which become adulterated is of
major public health importance, in view of the dangerous effects
which arise from administration of a potent drug which may
be contaminated or substituted in whole or in part by another
potent substance. An error in drug compounding may result
in a fatality.
Certification Services
FDA conducts several pre-distribution certification serv-
ices. Coal-tar dyes used in foods, drugs, and cosmetics for inter-
state distribution must be from batches which have been cer-
tified as harmless and suitable for intended use. In recent years
advanced pharmacological methods have shown that some of
the colors which were being certified were not free of toxicity.
Accordingly, steps were taken to remove them from the list
of certifiable colors. This resulted in litigation over the ques-
tion of whether the Secretary of Health, Education, and Welfare
had the authority under the law to establish safe tolerances for
those colors which were not safe in unlimited amounts. The
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Government contended that no such authority exists. The op-
position argued to the contrary. Two conflicting circuit court
opinions resulted. The matter is presently before The Supreme
Court of the United States.
Insulin and drugs containing penicillin, streptomycin,
chlortetracycine, chloramphenicol, and bacitracin or any of their
derivatives are also subject to certification procedures through
laboratory testing and labeling review before distribution. Each
batch must be certified as complying with the fixed standards.
New Drugs
From a public health standpoint, the new drug provisions of
the Act are constructive and an important contribution to the
safe use of drugs. Legally no new drug may be introduced into
interstate commerce except for investigational use by qualified
researchers unless an application giving full reports of all in-
vestigations, both experimental and clinical, the composition,
methods and controls of manufacture and proposed labeling for
the drug are submitted in a formal application to FDA to estab-
lish its safety.
Since 1938, over 11,000 new drug applications have been
submitted to FDA. In addition many thousands of supplements
to original applications have been cleared. Pharmacologists and
physicians play major roles in the development of new drugs
since they perform the necessary animal and clinical studies to
determine the safety of the drug. Their reports are submitted
by the manufacturer. It is essential that such reports be com-
plete and detail the full investigational experience.
The new drug regulations were rewritten and became ef-
fective August 24, 1956. Subsequently a portion of the regula-
tions dealing with investigational drugs was revised to remove
the requirements that shippers of new radioactive drugs obtain
signed statements from investigators when the consignee has
been licensed by the Atomic Energy Commission.
Enforcement Procedures
Under the Act, misbranded or adulterated goods may be
seized, the responsible persons may be prosecuted, or enjoined
from further interstate shipment. FDA has no embargo powers,
or other authority for summary action, such as those of State
and local jurisdictions, or cease and desist procedures, such as
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those employed by the Federal Trade Commission, which is re-
sponsible for enforcing advertising restrictions for foods, drugs,
devices, and cosmetics. The cases brought under the statutes
FDA enforces are heard in district courts and the adjudicating
processes are those of the courts and not of an administrative
body.
Before FDA recommends a case to the Department of
Justice, it must be prepared to produce convincing evidence that
the law has been violated. This may involve inspectional evi-
dence of interstate shipment; analytical evidence by chemist,
microanalyst, physicist, nutritionist, pharmacologist, physician,
or experts of other scientific disciplines that the product is not
what it purports to be; trade testimony that the practice is not
condoned; or establishment of a preponderance of medical opin-
ion as to the value of the product.
Actions under the Food, Drug, and Cosmetic Act follow the
procedures of admiralty law, insofar as possible, as directed by
the statute, except that jury trials may be had on request of
either party. Our search may be of two kinds-factory inspec-
tion and sampling of goods in interstate commerce. The first is
really a guide to the second and provides an orderly method of
conducting our operations. After a determination is made as to
where coverage is most needed to protect the public welfare,
we apportion our limited staff by geographic area and commodity
so that there will be uniform coverage throughout the Country.
When the U. S. marshal seizes products following the filing
of a libel, the claimant has the choice of abandoning the goods,
consenting to the seizure but salvaging fit portions under bond
and FDA supervision, or contesting the action in a Federal Dis-
trict Court. Seizure is usually our first recourse when we find
that violative articles are in channels of distribution.
Criminal Prosecution
The Act does not condone irresponsibility nor does it make
consciousness of wrongdoing an element of the offense. The Act
does, however, distinguish between conscious and unknowing
violations by establishing for misdemeanors of the mala prohib-
ita type, maximum one year prison and/or $1,000 fine penalties,
and for violations "with intent to defraud or mislead" or for
repeat violations, maximum penalties of 3 years imprisonment, a
$10,000 fine or both.
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Injunction
The sanction of a statutory injunction was added in the
1938 law. Primarily, this provision of the law has been employed
to prevent the interstate shipment of violative products while
still in the producer's possession. Injunction is a ready approach
when it becomes an undue burden to keep the goods under sur-
veillance and apprehend them before they reach the ultimate
consumer. For example, in a number of instances we have found
warehouses full of filth-contaminated foods. After we petitioned
the Federal Courts to prohibit their shipment for food use, they
were diverted into nonfood channels or reprocessed so that they
would meet the decencies the public expects of foods.
Injunction orders have also been effective against promoters
of nostrums, some knaves and others pathetically misguided, but
determined to cure mankind of all ills. Such persons have no
business encouraging diabetics to abandon insulin for their weed
concoctions, or others to risk their lives or health in seeking
cures for cancer and other serious diseases through worthless
drugs or mechanical contraptions.
Medical Quackery
Medical quackery is a great national health problem. There
is a strange contrast between the way society reacts to crimes
such as robbery, kidnapping or murder, and its comparative
indifference to quackery. Since there is no physical violence on
the part of the quack, society regards his chicanery benignly,
yet quackery has the same consequences to the individual as
those of the criminal who commits manslaughter. Organized
health groups are moving forward vigorously to eliminate this
great risk to the health of the people of our Nation. Beyond
taking legal actions against the responsible individuals, FDA
has also been actively engaged in public health education pro-
grams to alert the Nation of this serious health problem.
Drug Reactions Study
Drug adverse reaction reporting is currently the basis of a
pilot study to provide methodology for collecting such essential
data in order to protect the physician, the patient and the
pharmacist through accurate and revealing labeling of drugs.
This is jointly participated in by the American Association of
Medical Record Librarians in cooperation with the American
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Society of Hospital Pharmacists, American Medical Association
and American Hospital Association. Physicians who encounter
unusual or severe reactions are encouraged to report such ex-
periences promptly. FDA can be reached easily through its
Washington office or any of its District offices in 16 major cities.
FDA through its specialized staff maintains vigilance over
the national supply of foods, drugs, devices, cosmetics, caustics
and corrosives to assure the protection provided in the several
statutes it administers. Since the laws to be enforced are dy-
namic legal instruments, frequent congressional revisions are
necessary in order to keep them up to date as the needs arise.
Only with the public-spirited cooperation of physicians, at-
torneys, and other professional persons can the public health be
fully protected.
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